5379 篇
13902 篇
477791 篇
16278 篇
11761 篇
3926 篇
6531 篇
1251 篇
75586 篇
37735 篇
12156 篇
1656 篇
2859 篇
3417 篇
641 篇
1240 篇
1973 篇
4916 篇
3871 篇
5467 篇
新兴医药市场报告(2016-2020年)
Pharmerging Markets 2016-2020
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Global pharmaceuticals market
Market size and forecast
PART 06: Pharmerging markets
PART 07: Market landscape
Market size and forecast
Five forces analysis
PART 08: Market segmentation based on geography
PART 09: Market overview of Tier I countries
China
PART 10: Market overview of Tier II countries
Brazil
Russia
India
PART 11: Market overview of Tier III countries
Market size and forecast
PART 12: Market drivers
Social and private health insurance
Increase in healthcare spending
High incidence of diseases
Impact of patent cliff on mature markets
PART 13: Impact of drivers
PART 14: Market challenges
Affordability and access
High competition
Partial regulatory policies
Price pressure
PART 15: Impact of drivers and challenges
PART 16: Market trends
Strategic alliances
Increase in generic sales
Mergers and acquisitions
Early drug launches in pharmerging markets
PART 17: Vendor landscape
Competitive scenario
AstraZeneca
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Other prominent vendors
PART 18: Appendix
List of abbreviations
PART 19: Explore Technavio